⏳ Fetching live dividend data...
Home › Calculator › TKBIF Dividend Calculator 2026
Takara Bio Inc. · OTC
Price: $7.30 · Annual div: $0.12/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in TKBIF → $411.51 in 10 years · $23.73/month
Takara Bio Inc., a subsidiary of Takara Holdings Inc., is a Japan-based biotechnology firm established in Kusatsu in 2002. The company operates globally, with a presence in Japan, China, other Asian countries, the United States, and Europe, focusing on three primary areas: general biotechnology, contract development and manufacturing (CDMO) services, and gene therapy. The company offers a diverse portfolio of scientific products, including a wide array of reagents and specialized instruments. These encompass tools for genetic research and testing, in vitro diagnostic solutions for viral detection (such as those for coronaviruses), analytical reagents, and advanced single-cell analysis systems. They also supply essential reagents for gene expression studies, fluorescent protein series, genome-editing research, iPS cell research, and products for culturing and differentiating stem cells. These offerings are marketed under prominent brands like TaKaRa, Clontech, and Cellartis. In addition to its product line, Takara Bio provides extensive contract services. For regenerative medicine, this includes the production of viral vectors and gene-modified cells, alongside rigorous quality and safety testing, and comprehensive cell banking services. Their gene analysis and testing services cover a broad spectrum, from DNA sequencing and gut microbiome analysis to in-depth profiling of cancer-associated genes and the creation of cell lines through genome editing. Furthermore, Takara Bio is actively engaged in developing foundational platform technologies to support the advancement of biologics, particularly within the field of gene therapy.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open TKBIF position with:
Real after-tax yield depends on where you live and how you hold TKBIF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 1.58% | -1.22% | $158 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 1.34% | -1.46% | $134 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 1.26% | -1.54% | $126 / yr |
| 🇬🇧 UK ISA | 0% | 1.58% | -1.22% | $158 / yr |
| 🇬🇧 UK Taxable | 8.75% | 1.44% | -1.36% | $144 / yr |
| 🇨🇦 TFSA | 0% | 1.58% | -1.22% | $158 / yr |
| 🇨🇦 CA Taxable | 25% | 1.19% | -1.61% | $119 / yr |
| 🇦🇺 Super (pension) | 15% | 1.34% | -1.46% | $134 / yr |
| 🇦🇺 AU Taxable | 30% | 1.11% | -1.69% | $111 / yr |
| 🇩🇪 DE Taxable | 26.375% | 1.16% | -1.64% | $116 / yr |
| 🇫🇷 FR Taxable | 30% | 1.11% | -1.69% | $111 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $0.12/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
TKBIF pays quarterly — 4 times per year. Next ex-div: TBD.
How TKBIF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for TKBIF sourced from FMP /financial-growth endpoint — real data, not estimates.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the TKBIF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Takara Bio Inc. (TKBIF) is currently trading at $7.30, 69% below its 52-week high. The current dividend yield is 1.58% based on an annual payout of $0.12 per share.
Takara Bio Inc. (TKBIF) is a healthcare stock currently trading at $7.30 with a dividend yield of 1.58%. The company pays an annual dividend of $0.12 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings. Over the past 5 years, TKBIF has grown its dividend at a compound annual rate of 17.9%.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →